Accel-Rx, Canada’s national health sciences accelerator, identifies and supports promising early-stage companies developing therapeutics, diagnostics and medical devices. Accel-Rx provides seed capital and expertise to help fuel growth, creating a critical mass of investment-ready ventures equipped to become the next generation of anchor companies driving a globally competitive health sciences sector. Accel-Rx is a not-for-profit federal Centre of Excellence for Commercialization and Research.